TotalMarketCap

CorMedix

CRMDNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$407.259 M

$5.23 -7.69%

Close of 6 Nov 2026

As of 6 Nov 2026, CorMedix (CRMD) has a market capitalization of $407.3M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$311.7M

#2098 by revenue

Earnings

$163.1M

#1082 by earnings

Shares outstanding

77,944,324

Latest filing cover page

P/E ratio

2.5

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #200OculisOCS$419.1M
  2. #201Phathom PharmaceuticalsPHAT$413.0M
  3. #202CorMedixCRMD$407.3M
  4. #203Prothena Corp PublicPRTA$406.3M
  5. #204Relmada TherapeuticsRLMD$402.7M

What if CorMedix were worth as much as…

Open the what-if tool →

Gold $28.2T

$362,269.79

Per share 69,334× higher

Bitcoin $1.53T

$19,601.79

Per share 3,752× higher

Apple $5.02T

$64,350.84

Per share 12,316× higher

Or at a round number

$500.0M$1.00B$2.00B$5.00B

Where these numbers come from

Share counts and financials for CorMedix are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.